Trademark Overview
On Friday, January 19, 2024, a trademark application was filed for CANECT-HD with the United States Patent and Trademark Office. The USPTO has given the CANECT-HD trademark a serial number of 98365357. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 26, 2024. This trademark is owned by Neurocrine Biosciences, Inc.. The CANECT-HD trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing medical information to patients, medical professionals, and insurance companies in the field of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Online information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Providing pharmaceutical consultancy services
Providing medical research information in the field of pharmaceuticals and clinical trials focusing on Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders, for others; Conducting research in the field of pharmaceuticals for evaluating epidemiological results; Conducting research in the field of pharmaceuticals for evaluating patients in the field of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders
